A companion phase III trial reported a -10.9% reduction in visceral adipose tissue (a 21 cm decrease) in the tesamorelin group compared with -0.6% in the placebo group over the six-month efficacy phase, alongside significant improvements in trunk fat, waist circumference, and waist-hip ratio, with the authors concluding that tesamorelin reduces visceral fat by approximately 18% and improves body-image distress in HIV-infected patients with central fat accumulation, without significant side effects or disruption of glucose control
The medication itself creates natural fasting-like appetite suppression, so extended fasting windows might cause fatigue or electrolyte imbalances
Identification and Characterization of a Pancreatic Intrinsic Factor in the Dog
& Hartz, A
This combination of MSDC-0602K and the GLP-1 receptor agonist liraglutide produces synergistic benefits in this regard (Kamm et al., 2021), however, the downstream mechanisms connecting MPC2 activation to GLP-1 vesicular exocytosis are not fully addressed
Abelovska isnt surprised that many people are experiencing this side effect when using Ozempic and Wegovy injections, as the drug can cause rapid weight loss, particularly, she says, if youve just started using it